Menopausal Disorders - Pipeline Review, H2 2013

Global Markets Direct
September 20, 2013
39 Pages - SKU: GMD5121582
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023
10/7/2014 | published by: GlobalData
EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 Summary Allergic conjunctivitis is an inflammation of the eye resulting from an allergic reaction to allergy causing substances (external antigens) like pollen, dander, mold, or other substances. In  |  read more...
USD 3,995
Legionella Control (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s UK Legionella Control (UK) analysis is the most definitive and accurate study of the UK Legionella Control (UK) sector in 2014. The report is split into two sections and uses both a written and graphical  |  read more...
USD 560
Biotechnology (Pharmaceuticals) (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
Plimsoll’s Biotechnology (UK) analysis is the most definitive and accurate study of the Biotechnology (UK) sector in 2014. The report is split into two sections and uses both a written and graphical analysis – analysing the  |  read more...
USD 1,520
Neonatal Ventilator Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
Neonatal Ventilator Market in India - 2014 This report provides an insight into the Neonatal Ventilator current market scenario, structure and practices in India. In depth market scenario includes; Market estimate of Neonatal Ventilator in India for FY14 Geographical  |  read more...
USD 1,500
EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
10/15/2014 | published by: GlobalData
Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary Wind Power in Australia, Market Outlook to 2025, Update 2014 - Capacity,  |  read more...
USD 3,995
KOL Insight: Multiple Sclerosis
10/6/2014 | published by: FirstWord
Introduction Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will  |  read more...
USD 6,495
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014
9/22/2014 | published by: Global Markets Direct
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2014’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report  |  read more...
USD 2,000
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023
9/30/2014 | published by: GlobalData
Apache Corporation, Company Intelligence Report Summary Apache Corporation (Apache) is a Texas-based independent oil and gas company involved in the exploration, exploitation, development and production of onshore and offshore oil and natural gas properties in five countries:  |  read more...
USD 4,995
Dystonia - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
Dystonia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Dystonia - Pipeline Review, H2 2014’, provides an overview of the Dystonia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dystonia, complete with comparative  |  read more...
USD 2,000
Lyme Disease - Pipeline Review, H2 2014
9/10/2014 | published by: Global Markets Direct
Lyme Disease - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Lyme Disease - Pipeline Review, H2 2014’, provides an overview of the Lyme Disease’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Lyme  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!